Platinum-sensitive Recurrent Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Platinum-sensitive Recurrent Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial of Iparomlimab/Tuvonralimab with standard chemotherapy and Olaparib in platinum-sensitive recurrent ovarian cancer; currently …
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer [Phase 4]
Phase 4 trial comparing trabectedin plus pegylated liposomal doxorubicin versus platinum-based therapy in platinum-sensitive recurrent ovari…
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: Niraparib and Bevacizumab Maintenance Therapy in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor [Phase 2]
Phase 2 trial update evaluating niraparib and bevacizumab as maintenance therapy in platinum-sensitive recurrent ovarian cancer patients pre…